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Abstract
Cancer is a common and deadly disease in the United States with 1,806,590 new
cancer cases in 2019 and 606,520 cancer deaths projected in 2020. These deaths are
primarily due to the uncontrolled cell proliferation and migratory nature of the disease.
Many cancer cells express genes normally restricted to meiotic cells. For example,
Aurora Kinase C (AURKC) is known to regulate chromosome segregation in meiotic cells
yet it is expressed in many different types of cancer, such as breast, prostate, colorectal,
liver, cervical, thyroid, and testicular cancers. As a means to study the function of
AURKC, an inducible expression vector was transiently transfected into the normal,
human retina pigmented epithelial (RPE) cell line lacking tumor suppressor gene TP53.
To characterize the gene’s oncogenic potential, the AURKC transfected-RPE cell line was
subjected to the following assays: Sulforhodamine B (SRB) Assay for cell proliferation;
Scratch Assay for cell migration; and Soft Agar Assay for cell growth/survival within
suspension. AURKC expression significantly increased cell migration and ability to grow
in soft agar. As for the SRB cell proliferation assay, there was no significant difference
over 72 hours between cells with and without expression of AURKC. Based on this series
of experiments, the conclusion can be made that AURKC displays oncogenic potential
through its effects on cell migration and anchorage independent growth, but more
experimentation, specifically cell proliferation over longer periods of time as well as
ability of cells to form tumors in nude mice, could be conducted. AURKC would be an
excellent therapeutic target to be investigated in the future because it is not expressed in
normal somatic cells limiting potential side effects.
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Introduction
Cancer is a leading cause of death in the United States and is characterized by
unregulated cell proliferation with metastatic potential. Cancer cells exhibit many traits
uncharacteristic of normal cells including the expression of meiosis-specific genes. Some
of these genes are known as cancer/testis (CT) genes. CT gene products, such as antigens,
are typically restricted to the testis in non-cancer patients, but are aberrantly expressed in
cancer patients. While many studies have been conducted on the use of CT genes as
viable biomarkers for cancer detection and diagnosis (Scanlan et al., 2004) and targets for
therapies (Xie et al., 2019), limited studies have been performed to investigate their
specific functions. Aurora Kinase C (AURKC), which regulates chromosome segregation
during meiotic cell division (Balboula & Schindler, 2014), is known to be aberrantly
expressed in numerous cancer subtypes including breast, prostate, colorectal, liver,
cervical, thyroid, and testicular cancers (E. Baldini et al., 2010; Enke Baldini et al., 2011;
Kimura et al., 1999; Tsou et al., 2011; Ulisse et al., 2006; Zekri et al., 2012) (Table 1).
While the function of AURKC in cancer cells is unclear, patient survival is decreased
with increased copy number (Figure 1) (Smith & Sheltzer, 2018) suggesting an
involvement in oncogenic signal transduction pathways.
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Table 1: Summary of cancer types with significant AURKC expression. Based on previous literature, the cancer subtypes listed above have been
shown to significantly express AURKC.
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Figure 1: Glioblastoma Multiforme patient survival with low and high copy number of Aurora kinase C. Adapted from “Systematic
identification of mutations and copy number alterations associated with cancer patient prognosis,” by J. C. Smith; J. M. Sheltzer, 2018;7,
Elife, doi: 10.7554/eLife.39217.
3

The Aurora kinase family, consisting of Aurora Kinase A, B, and C, are a group of
serine/threonine kinases involved in the regulation of chromatid segregation during mitosis and
meiosis. Mitosis is a process in which the end goal is to segregate sister chromatids evenly into
the two resulting daughter cells. Meiosis is a specialized type of cell division in which two
rounds of cell division result in the formation of haploid daughter cells. Any errors in the
functionality of cell division can lead to instability in the genome, which in turn can lead to
tumorigenesis (Sasai et al., 2004).
Each member of the Aurora Kinase family fulfils a particular role in the cell division
process (Bernard et al., 1998). Aurora Kinase A (AURKA) is expressed in all cells of the body
and localizes to the centrosomes where it segregates centriole pairs and aids in the maturation of
centrosomes necessary for bipolar spindle formation (Marumoto et al., 2005). Aurora Kinase B
(AURKB) is also expressed in all cells of the body and is directly involved in the chromosomal
passenger complex (CPC). The CPC is also composed of an inner centromere protein (INCENP),
survivin, and borealin and regulates chromosome segregation, kinetochore microtubule
association, and cytokinesis (Carmena & Earnshaw, 2003). In the event errors in microtubule
attachment to the kinetochores of the sister chromatids occur, AURKB acts as a proofreading
mechanism, fixing any improper kinetochore binding (Giet & Glover, 2001; Vader et al., 2006).
In addition to these functions, AURKB is also directly involved in the recruitment of spindle
assembly checkpoint (SAC) proteins to kinetochores (Ditchfield et al., 2003; Vigneron et al.,
2004; Santaguida et al., 2011) and indirectly maintains stable kinetochore–microtubule
attachments (De Antoni et al., 2012; Wang et al., 2012). Aurora Kinase C (AURKC) is only
expressed in meiotic cells and can act as the catalytic subunit of the CPC. With AURKC and
AURKB having a 75% identical sequence homology (Quintas-Cardama et al., 2007), each
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performs a similar function in terms of chromosome segregation in the cell and regulation of the
SAC by correcting the faulty attachments between spindle fibers and kinetochore, maintaining
the correct chromosome alignment, and ensuring proper chromosomal segregation. The main
difference is that AURKC is more active in meiosis as opposed to mitosis (Tang et al., 2006).
AURKC, also known as Aurora 3 or Aurora/IPL1-related kinase 3 was discovered by
three independent laboratories in the late 1990s (Gopalan et al., 1997; Bernard et al., 1998;
Tseng et al., 1998). AURKC is cytogenetically located on the long (q) arm of chromosome 19 at
position 13.43 (19q13.43). As a product of alternative splicing, there are three protein variants of
AURKC, variants 1, 2, and 3, with the lack of amino acid residues on the N-terminus of variants
2 and 3 being the primary difference to variant 1 (Bernard et al., 1998; Tseng et al., 1998; Yan et
al., 2005).
In previous studies, AURKC has been known to be expressed at low levels in normal
skeletal muscle, placenta, lung, and bladder somatic cells (Yan et al., 2005), as well as in germ
cells and breast, cervical, and liver cancer cells at higher levels (Assou et al., 2006; Kimura et al.,
1999). AURKC expression is highest during M phase of the cell cycle due to the localization and
activity of AURKC beginning and primarily occurring between metaphase and anaphase (Tang
et al., 2006). Within the cell, AURKC’s localization behavior mimics that of both AURKA and
AURKB during mitosis as it localizes to spindle poles and chromosomes in metaphase, and the
spindle midzone in anaphase (Balboula et al., 2016; Balboula & Schindler, 2014; Nguyen et al.,
2014).
It is known that AURKB and AURKC have multiple overlapping functions and are even
inversely correlated, with an overexpression of AURKC decreasing the expression level of
AURKB in colon carcinoma cancer cells (Tsou et al., 2011), however, little is known about their
5

non-overlapping functions. Non-overlapping functions are known to exist between the two
kinases, at least meiotically, as one study found significantly decreased fertility and increased
embryonic lethality in AURKB inhibited mice populations compared to AURKC inhibited
populations, suggesting each has a novel role that is not shared with the other (Nguyen et al.,
2018). These differences could be linked to two different CPC complexes, one specific to
AURKB and the other to AURKC, that differ in the catalytic activity levels (Nguyen &
Schindler, 2017; Sasai et al., 2016). It remains to be seen if this also holds true in mitotic cells.
AURKC seems to a play a role in cancer. In addition to being aberrantly expressed in
numerous cancer subtypes (Table 1). A study displayed the oncogenic ability of AURKC via
increased proliferation, migration, and promotion of tumor formation in xenograft animal studies
when overexpressed in cancer cells (Tsou et al., 2011). Another study demonstrated the ability of
AURKC to transform normal mouse fibroblast cells (NIH-3T3) (Khan et al., 2011). In breast and
prostate cancer cell line models, overexpression of AURKC was shown to induce spindle defects,
chromosome mis-segregation, and malignant transformation (Zekri et al., 2012). Despite these
results, the definitive functional role of AURKC in tumor development, what pathways it affects,
and its role as a potential oncogene is still unclear (Zekri et al., 2012). This study is the first to
use a near diploid, human cell line to evaluate the oncogenic potential of AURKC which allows a
more precise understanding of the functional significance of AURKC in human tumors. The
findings from this study identify AURKC as a potential target for cancer therapy. Because this
meiosis-specific gene is not expressed in mitotic cells, therapies targeted against it would
specifically harm cancer cells limiting the toxic side effects of current cancer treatments.
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Materials and Methods
Cell Culture
Non-transformed human diploid cells, Retina Pigmented Epithelial Cells
(hTERT-RPE-1) lacking p53 (p53-/-) were a generous gift from Dr. Iain M. Cheeseman
(MIT Department of Biology) and were maintained with Dulbecco’s Modified Eagle
Medium (DMEM) (Sigma-Aldrich, St. Louis, Missouri), along with 10% TetracyclineFree Fetal Bovine Serum (Takara Bio, Mountain View, CA) and 1% PenicillinStreptomycin (Gibco, Gaithersburg, MD). Various RPE-1 p53-/-cell lines were generated
by transfecting a pTetOne inducible expression vector (Takara Bio) with or without
human Aurora Kinase C (hAURKC) (Genecopoeia, Rockville, MD) (Sequence found in
Appendix). Cells were maintained under incubator conditions of 37°C and 5% CO2 and
were frozen in 30% Dulbecco’s Modified Eagle Medium (DMEM), 60% TetracyclineFree Fetal Bovine Serum, and 10% dimethyl sulfoxide (DMSO) (VWR Life Science,
Radnor, Pennsylvania).
Vector Linearization, Gene of Interest Amplification, and Infusion Cloning
DNA Cloning is a recombinant DNA technique in which specific cDNAs or
fragments of genomic DNA of interest (GOI) are inserted into a circular piece of DNA
called a plasmid or vector. For a cloning vector to be viable it must include three
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functional regions: an origin of replication, a drug-resistance gene, and a region where
DNA can be inserted without interfering with plasmid replication or expression of the
drug-resistance gene (Griffiths et al., 1999). In this technique, DNA plasmids are
linearized using restriction enzymes to cut specific 4- to 8-bp sequences, often leaving
self-complementary single-stranded tails, known as sticky ends (Smith, 1993). Next, a
gene of interest, with primers complementary to the sticky ends created by the restriction
enzymes, is amplified using polymerase chain reaction (PCR). When the GOI DNA
fragment and linearized plasmid vector with complementary ends are introduced to each
other under the proper conditions, an Infusion Cloning reaction will occur, and DNA
ligase will form phosphodiester bonds between the restriction fragment and vector DNA
to form a functional plasmid-GOI vector (Lodish et al., 2000).
Two µg of pTetOne was linearized with EcoRI and BamHI (New England
Biolabs, Ipswich, MA) according to manufacturer’s protocol. Linearization product was
dyed using 6X TriTrack DNA Loading Dye (Thermo Fisher Scientific, Waltham, MA)
and run on a 1% agarose (Invitrogen, Carlsbad, CA) gel along with a 1kb Ladder
(Amresco, Solon, OH) in a MiniRun DNA Gel Electrophoresis system (BIOTANG Inc,
Albuquerque, NM) at 100V in 0.5X w/v Tris-acetate-EDTA (TAE) (Invitrogen). Forward
and reverse primers (Sequences found in Appendix) (Integrated DNA Technologies,
Coralville, IA), coinciding with overhanging “sticky ends” of linearized pTetOne vector,
were designed to be attached to hAURKC (Genecopoeia, Rockville, MD) (Genecopoeia).
Using the CloneAmp™ HiFi PCR Premix kit (Takara Bio, Mountain View, CA)
100 ng of hAURKC (Genecopoeia) and 10 pmol of the designed forward and reverse
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primers were annealed together and amplified, followed by clean-up using a NucleoSpin
Gel and PCR Clean-up Kit (Macherey Nagel, Bethlehem, PA). The PCR product of
hAURKC was then inserted into 50 ng of linearized pTetOne vector with the Infusion®
HD Cloning Kit (Takara Bio).
Stellar Competent Cell Transformation and DNA Extraction
During transformation a plasmid is inserted into competent bacteria cells,
typically E. coli, which produce large quantities of recombinant DNA molecules (Carter
et al., 2015). These transformed cells are selected for by plating on nutrient agar
containing the selection antibiotic. Only bacteria cells containing the plasmid, which
carries the drug-resistance gene, will survive. All of the cells grown within a colony
contain identical plasmids, as they are descendants from the single plasmid that
transformed the first cell of the colony (Pelley, 2007). Once the isolated colony of
transformed cells has grown sufficiently, the DNA from them is extracted to be used for
further experimentation.
The hAURKC-pTetOne or empty pTetOne vectors were transformed into
Stellar™ Competent Cells (Takara Bio, Mountain View, CA) and plated onto LB agar
plates containing 50 µg/mL ampicillin (Sigma-Aldrich, St. Louis, Missouri). Some viable
colonies were isolated and grown up in 6 mL LB Broth + 6 µL 50 mg/mL ampicillin
starter cultures overnight. DNA was extracted via NucleoBond® Xtra Mini EF
(Macherey Nagel, Bethlehem, PA) and concentrations were determined using a
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NanoDrop™ 1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA) with
ND-1000 version 3.8.1 software (Thermo Fisher Scientific).
Glycerol Stock Preparation
Prior to DNA extraction from viable transformed colonies, over dry ice, 1 mL of
the viable colony culture and 500 µL of 80% glycerol (Thermo Fisher Scientific,
Waltham, MA) were made into a homogeneous mixture and were stored at -80 °C.
Transient Transfection and Induced Expression
Transfection is the process of introducing nucleic acids (DNA or RNA) into cells
artificially. Chemical, biological, or physical methods of introducing foreign nucleic can
result in a change of the properties of the cell, allowing the study of gene function and
protein expression in the context of the cell (Kim et al., 2010). In transfection, the
introduced nucleic acid can exist in the cells transiently, where it is only expressed for a
limited period of time or limited number of cell passages and does not replicate, or it may
be stably integrated into the genome of the recipient cell, replicating when the host
genome replicates (Stepanenko et al., 2017). In the scope of our experimentation,
transient transfection was performed as a means to induce hAURKC expression in human
retina pigmented epithelial cells; a cell line that does not typically express hAURKC.
Using the Xfect™ Transfection Reagent Kit (Takara Bio, Mountain View, CA), 5
µg of hAURKC-pTetOne and empty pTetOne vectors were transfected into RPE-1 p53-/cells. 24 hours post-transfection, the cells were treated with 100 ng/µL doxycycline
(Sigma-Aldrich, St. Louis, Missouri) dissolved in Milli-Q water, purified by a
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MilliporeSigma™ Milli-Q™ Integral System (Fisher Scientific, Hampton, NH), to
induce hAURKC expression. 48 hours post-doxycycline treatment, cells were collected to
be used in Sulforhodamine B (SRB), scratch, and soft agar assays.
RNA Isolation and qPCR
RNA was isolated from cell pellets using NucleoSpin RNA Plus Kit (Macherey
Nagel, Bethlehem, PA) followed by clean-up using NucleoSpin RNA Clean-up XS Kit
(Macherey Nagel) and resuspended in 15 µl of RNase free water. Up to 5 µg of RNA was
reverse transcribed to create cDNA. The cDNA was then used as the template for qPCR
utilizing Taqman probes for hAURKC and 18S (Applied Biosystems, Foster City, CA)
and an Applied Biosystems StepOnePlus™ Real-Time PCR System (Applied
Biosystems, Foster City, CA).
Sulforhodamine B (SRB) Assay
Cell proliferation was determined using a protocol previously described (Orellana
et al., 2016). Briefly, transiently transfected and doxycycline-treated cells were plated in
quintuplicates into four separate 96-well plates at a density of 5,000 cells/well. Each plate
was incubated for a designated amount of time (3 hours, 24 hours, 48 hours, or 72 hours).
After incubation period, cells were washed with 1X Phosphate Buffered Saline (PBS) and
fixed to the plate using 20% trichloroacetic acid solution (Sigma-Aldrich, St. Louis,
Missouri). After all plates were fixed, they were washed with tap water, stained with 1%
acetic acid + Sulforhodamine B v/w (Sigma-Aldrich), and imaged for absorbance at 505
nm wavelength using a Varioskan™ LUX multimode microplate reader (Sigma-Aldrich,
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St. Louis, Missouri). Fold change was determined by dividing average absorbance of
each time point by the average absorbance of the cell line on Day 0 (3 hours after
plating).
Scratch Assay
Transiently transfected and doxycycline-treated cells were plated in
quadruplicates into a 24-well plate at 150,000 cells/well to create a monolayer. Once a
single monolayer formed, a vertical scratch was made using a new P1000 pipette tip for
each well. A photo of the initial scratch was taken using an ACCU-SCOPE Excelis HD
Camera – 1080p (Accu-Scope Inc, Commack, NY) under an ACCU-SCOPE EXI-310
Trinocular Inverted Microscope (Accu-Scope Inc) at 4X magnification. After 18 hours, a
photo of the original scratch area was taken. The area of the scratch was analyzed using
ImageJ software (NIH). Percent scratch closure was calculated by measuring the final
area of the scratch relative to the initial area.
Soft Agar Assay
Transiently transfected and doxycycline-treated cells were plated in triplicates
into a 24-well plate at 5,000 cells/well. Cells were maintained in a suspension layer of 1X
DMEM Media and 0.35% w/v agar above a base layer of 1X DMEM Media and 0.5%
w/v agar. Dulbecco’s Modified Eagle Medium (DMEM) along with 10% TetracyclineFree Fetal Bovine Serum (Takara Bio, Mountain View, CA) and 1% PenicillinStreptomycin were added to each well as overlay media and replaced every 4 days.
Pictures of each well were taken after 14 days in culture with an ACCU-SCOPE Excelis
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HD Camera – 1080p under an ACCU-SCOPE EXI-310 Trinocular Inverted Microscope
at 4X magnification. Pictures were blinded and colonies counted.
Statistical Analysis
Data are presented as mean ± standard error, with statistical significance
determined by t-test or one-way ANOVA using GraphPad Prism software (GraphPad, La
Jolla, CA) for p ≤ 0.05. All data sets were analyzed for significant outliers with Grubbs’
test of deviation.
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Results
Cloning
Within the scope of our experimentation, the gene of interest was human Aurora
Kinase C (sequence found in Appendix) and the cloning vector used was pTetOne, a
plasmid with an incorporated doxycycline-inducible expression system to control GOI
expression and ampicillin antibiotic resistance. An inducible expression plasmid model
was selected for this experiment due to experiments conducted previously displaying
premature cell death with the use of a constitutive promoter plasmid model (unpublished
data).
First, the pTetOne vector was linearized using the restriction enzymes: BamHI
and EcoRI, as a means to linearize the vector for the hAURKC insertion. The nucleic acid
recognition sequence for BamHI is between base 4170 and 4171 of the pTetOne plasmid,
where the enzyme cuts site recognizes a G/GATCC sequence, cutting between the two
Gs. The nucleic acid recognition sequence for EcoRI is between base 4202 and 4203 of
pTetOne, where the enzyme cuts site recognizes a G/AATTC sequence, cutting between
the G and A. The linearized vector of the size 4207 bp was confirmed via gel
electrophoresis on a 1% gel (Figure 2).
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Figure 2: Confirmation of linearized pTetOne vector. 1% Agarose gel electrophoresis image confirms size
(4207 bp) of linearized pTetOne vector. Well 1: DNA ladder (1 kb ladder), Well 2: Linearized pTetOne vector.
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Next, the hAURKC gene was amplified using primers complementary to the
pTetOne overhanging ends (sequences found in Appendix), using the CloneAmp™ HiFi
PCR Premix kit, followed by a PCR cleanup to mitigate background interference.
Amplification was confirmed via gel electrophoresis indicating DNA of 928 bp (Figure
3). The linearized pTetOne vector and primer-incorporated hAURKC DNA fragment
were then combined in an Infusion reaction to create a hAURKC-pTetOne vector.
The hAURKC-pTetOne vector product from the Infusion reaction was
transformed into Stellar™ Competent E. coli HST084 cells and plated on LB agar plates
containing ampicillin. Any colonies growing on these plates would reflect that they have
been successfully transformed with the hAURKC-pTetOne vector, which has an
ampicillin-resistant gene incorporated into it. Seven colonies were randomly selected and
grown in ampicillin-present LB Broth at a volume suitable for DNA Extraction
(Midiprep). To confirm the presence of hAURKC and rule out self-annealing of the empty
pTetOne vector, isolated DNA was amplified with the CloneAmp™ HiFi PCR Premix kit
using the same hAURKC/pTetOne primers from the Infusion cloning reaction
(Appendix). The purified PCR products were submitted to Genewiz for sequencing.
Alignment of the sequences compared to hAURKC revealed that all 7 colonies contained
the gene of interest (Figure 4). For all future experiments, DNA extracted from colony
labeled 403 was used.
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Figure 3: Confirmation of amplified hAURKC gene. 1% Agarose gel electrophoresis image confirms size
(928 bp) of the amplified hAURKC gene. Well 1: DNA ladder (100 bp ladder), Well 2: Amplified hAURKC
gene.
17

Figure 4: Verification of insert with Sanger Sequencing. Using Molecular Evolutionary Genetics Analysis (MEGA)
software an alignment analysis was performed comparing the known coding AURKC sequence with DNA amplified
from 7 randomly selected colonies. Alignment confirmed the presence of AURKC in the vector.
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Transient Transfection
hAURKC-pTetOne vector was transiently transfected into RPE p53-/-cells,
doxycycline treated for 48 hours, and pelleted for RNA isolation. A qPCR was performed
to confirm the expression of hAURKC in these transiently transfected cells (Figure 5).
Doxycycline-treated transiently transfected cell relative expression displayed consistently
(n = 5) higher levels of expression compared to normal RPE (with a functional p53 gene)
control and non-doxycycline treated samples.
Characterization
In this study, a characterization of the oncogenic potential of AURKC was
evaluated through the subjection of the hAURKC-pTetOne transfected-RPE p53-/- cell line
to the following assays: Sulforhodamine B (SRB) Assay for cell proliferation, Scratch
Assay for cell migration, and Soft Agar Assay for cell growth and survival within
suspension. Each of these assays was performed on two populations of the hAURKCpTetOne transfected RPE p53-/-cells; one treated with doxycycline (Doxy+) and the other
untreated with Doxycycline (Doxy-) to serve as a control. As seen in Figure 5, AURKC
expression is induced in hAURKC-pTetOne transfected cells when exposed to
doxycycline.
An SRB Assay was used to measure cell proliferation, due to the electrostatic
nature of Sulforhodamine B dye to bind to the proteins of trichloroacetic acid-fixed cells
while under mild acidic conditions (Orellana et al., 2016). The amount of dye bound to
the proteins can be quantified as a representation of cell mass through absorbance.
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Figure 5: RT-qPCR assay measuring relative gene expression levels of AURKC via ΔΔ
Ct method. One population of hAURKC-pTetOne RPE p53-/- transfected cells were treated
with 100 ng/µL doxycycline (Doxy+) to induce AURKC expression and another population
was left untreated (Doxy-) to serve as a control with AURKC expression absent. *denote
statistically significant differences between RPE and pTetOne AURKC Doxy+ as determined
by one-way ANOVA; p value = 0.0331. Error bars represent mean±SEM.
20

Within the scope of this project, the Doxy+ and Doxy- populations were each
plated and fixed with trichloroacetic acid after being incubated for the following amounts
of time: 3 hours, 24 hours, 48 hours, and 72 hours and then dyed with Sulforhodamine B
and imaged to measure for absorbance. Based on a two-sample t-test (p ≤ 0.05) of the
average daily fold changes, the cell proliferation rates were not shown to be statistically
different between the Doxy- and Doxy+ populations at any of the time points tested
(Figure 6) after five replicates. On days 1 and 2, the fold change of both cell populations
was nearly identical (1.31 vs. 1.41 and 2.67 vs. 2.60 for Doxy- and Doxy+ cells,
respectively). At day 3, the amount of cell proliferation in the Doxy+ population was
lower than that of the Doxy- (4.00 vs. 4.53), however not statistically significant.
A Scratch Assay is an in vitro method used to measure the rate of cell migration
through a “scratch” or artificial gap on a confluent cell monolayer. The borders or edges
of the “scratch” move towards the opening to close the “scratch” for a set amount of time
or until the cells at each of the borders of the scratch connect again (Liang et al.). After
establishing cell monolayers of the Doxy- and Doxy+ cell populations in their own
respective plates, images of the initial scratch in the monolayer were taken (Figure 7A
and 7C). After an 18-hour incubation period, images were captured for both of the
populations of cells (Figure 7B and 7D). A ratio of the area of the wound following 18hour incubation period over the initial wound area was used to calculate the percent of
wound remaining open. One minus the percent wound open was used to determine the
percent wound closure. The average percent closure for the Doxy- cell population was
66.31% while it was 82.30% for the Doxy+ cell population (n=5) (Figure 8). A two-
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sample t-test of the average percent closures showed a significant difference with a p
value of 0.0465.

22

Figure 6: SRB assay measuring cell proliferation in hAURKC-pTetOne transfected
RPE p53-/-cells via fold change. One population of hAURKC-pTetOne RPE p53-/transfected cells treated with 100 ng/µL doxycycline (Doxy+) to induce AURKC
expression and another population was left untreated (Doxy-) to serve as a control with
AURKC expression absent. Cells were fixed with 20% trichloroacetic acid after being
incubated for 3 hours, 24 hours, 48 hours, 72 hours, dyed with 1% acetic acid +
Sulforhodamine B v/w and absorbance was measured at 505nm. Fold change was
calculated by dividing absorbance by the initial absorbance of the cells 3 hours after
plating. Error bars represent mean±SEM.
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D

Figure 7: Representative scratch assay images at hour 0 vs hour 18. Artificial wound in cell monolayer of untreated (Doxy-) hAURKC-pTetOne
transfected RPE p53-/- cells (A) and doxycycline treated (Doxy+) hAURKC-pTetOne transfected RPE p53-/- cells (C) after the initial scratch, Hour 0.
Artificial wound closing 18 hours post scratch, Hour 18, untreated (Doxy-) hAURKC-pTetOne transfected RPE p53-/- cells (B) and doxycycline treated
(Doxy+) hAURKC-pTetOne transfected RPE p53-/- cells (D). Red lines indicate borders of the scratch.
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Figure 8: Scratch assay measuring cell migration in hAURKC-pTetOne transfected RPE p53-/cells via percent closure. One population of hAURKC-pTetOne RPE p53-/- transfected cells were
treated with 100 ng/µL doxycycline (Doxy+) to induce AURKC expression and another population
was left untreated (Doxy-) to serve as a control with AURKC expression absent. Cell monolayers were
established and scratched using a sterile P1000 pipette tip. Images at time of the initial scratch and 18
hours post scratch were captured and compared to determine percent closure. *denote statistically
significant differences between treatment groups where appropriate as determine by t-test; p value =
0.0465. Error bars represent mean±SEM.
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A Soft Agar Assay is an in vitro method used to characterize anchorageindependence, or the ability to grow independently of a solid surface, a trait associated
with transformed cells (Borowicz et al., 2014). In this assay, Doxy- and Doxy+ cells were
grown in a layer of soft agar mixed with tetracycline-free cell culture medium, which
rested on another layer of soft agar, also mixed with tetracycline-free cell culture
medium, but containing a higher concentration of agar and without any cells growing in
it. After the bottom layer and the cell present layer have been established, a culture
medium feeding layer was overlaid as the topmost layer to provide nutrients to the cells
(Figure 9). The bottom layer prevents the cells from anchoring to the culture plate, but
still allows for transformed cells to form visible colonies (Figure 10). After 14 days in
culture, the average number of colonies in wells containing the Doxy+ cells were higher
than that observed in the wells containing Doxy- cells (7.467 Doxy+ colonies vs 5.267
Doxy- colonies). This difference was statistically significant based on a two-sample t-test
with p = 0.0432 (Figure 11).
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Figure 9: Cartoon depicting soft agar assay three-layer arrangement and layer contents.
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Doxy+ Colony Growth

Doxy- Colony Growth

Figure 10: Representative images of anchorage-independent growth. hAURKC-pTetOne
transfected RPE p53-/- colonies formed in Doxy+ and Doxy- soft agar plates after 2-week growth
period. Cells within yellow circles represent a counted colony.
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Figure 11: Soft agar assay characterizing anchorage-independent cellular transformation in
hAURKC-pTetOne transfected RPE p53-/-cells via colony growth in suspension. One population of
hAURKC-pTetOne RPE p53-/- transfected cells were treated with 100 ng/µL doxycycline (Doxy+) to
induce AURKC expression and another population was left untreated (Doxy-) to serve as a control with
AURKC expression absent. Doxy+ and Doxy- cells were set in a layer of 0.35% agar and 1X cell culture
media and plated between a bottom layer of 0.5% agar and 1X cell culture media and a top feeding layer
of 500 µL 1X cell culture media. Cells were incubated to grow for a 2-week period with regular
replacement of feeding layer media. Visible colonies were counted and recorded. *denote statistically
significant differences between treatment groups as determine by t-test; p value = 0.0432. Error bars
represent mean±SEM.
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Discussion & Conclusion
Based on recent studies, AURKC has been revealed to be aberrantly expressed in
numerous cancer subtypes including breast, prostate, colorectal, liver, cervical, thyroid,
and testicular cancers (E. Baldini et al., 2010; Enke Baldini et al., 2011; Kimura et al.,
1999; Tsou et al., 2011; Ulisse et al., 2006; Zekri et al., 2012). In these cancer subtypes,
AURKC has been shown to increase cell proliferation and migration, as well as promote
tumor formation in xenograft animal studies (Tsou et al., 2011), suggesting AURKC as a
potential oncogene, although the oncogenic activity of AURKC is still in dispute (Zekri et
al., 2012). While previous studies have demonstrated the ability of AURKC to transform
normal mouse fibroblast cells (NIH-3T3) (Khan et al., 2011), this is the first study to
present the effects of AURKC expression on cell migration, cell proliferation, and
anchorage independent growth in retina pigmented epithelial cell line (RPE-1) for its near
diploid status (90%) as reported by the American Type Culture Collection (ATCC). The
tumor suppressor gene p53 was deleted from the cells to prevent cell cycle arrest. The use
of a human cell line model in the scope of this study allows for the development of a
more precise understanding of the functional significance of AURKC in human cancers.
After SRB assay growth periods of 24, 48, and 72 hours, the fold change
exhibited by Doxy+ AURKC Expressive RPE p53-/- cells and Doxy- AURKC Absent
RPE p53-/- cells did not yield statistically significant different results. This was an
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unexpected result as previous studies (Baldini et al., 2011; Tsou et al., 2011) suggest
AURKC expression plays a role in increasing cell proliferation rates. The inconsistency
between findings in this study and previous studies could be attributed to the levels of
AURKC expression, as the Khan 2011 study found successful transformation of NIH 3T3
mouse cells was correlated to the quantity of active kinase expression. The RPE p53-/- cell
line used in this study do not express measurable levels of AURKC naturally and the
transient transfection of the hAURKC-pTetOne vector would, in principle, induce an
overexpression of AURKC. However, due to the nature of a transient transfection, the
expression of AURKC may not reach the same level of overexpression exhibited in the
cancer cell lines (Zekri et al., 2012). The cancer cell lines used in these previous studies
may also have additional mutations to cell proliferation pathways that enhance the effects
of AURKC expression. In addition, the limited growth periods used in this study may
have attributed to the discrepancy between the results in this and previous studies.
Prolonged growth periods surpassing 72 hours may result in different growth rates and
could be investigated in the future.
The Scratch assay and Soft Agar assays in this study revealed that Doxy+
AURKC Expressive RPE p53-/- cells displayed a higher rate of cell migration and more
colonies in soft agar compared to the Doxy- AURKC Absent RPE p53-/- cells. These
findings agree with previous studies performed in normal mouse cells or human cancer
cells (Khan et al., 2011; Tsou et al., 2011) suggesting that gain of AURKC activity is
sufficient for cell transformation. A xenograft animal model implanted with the AURKC-
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transfected cell line testing for tumor growth could be performed to attain more definitive
results regarding the oncogenic potential of AURKC.
The transformative ability associated with AURKC expression reported in this
study could be due to the downregulation of AURKB expression (Tsou 2011, Nguyen
2018). AURKB is a protein associated with the regulation of kinetochore–microtubule
attachment (Slattery et al., 2009), a mechanism directly involved in chromosome
stability. The downregulation of functional AURKB, as result of AURKC expression
replacing its presence in the CPC, could create chromosomal instability which in turn
facilitates tumorigenicity. While AURKB and AURKC have many overlapping
functions, previous studies have shown that AURKC is less efficient at activating the
spindle assembly checkpoint (SAC) in meiotic cells (Quartuccio et al., 2017). Perhaps
AURKC expression in mitotic cells causes more cells to bypass the SAC resulting in
improper chromosome segregation, aneuploidy, and genomic instability characteristic of
tumorigenicity in cancer cells. Future experiments could measure the levels of AURKB
in Doxy+ AURKC Expressive RPE p53-/- cells and measure SAC activity to determine if
this is a possible mechanism of oncogenic activity of AURKC.
AURKC may also play a non-mitotic role in cells contributing to cell migration.
AURKA has been shown to increase cell migration via tubulin polymerization
enhancement, a process that facilitates increased formation of microtubules which serve
as the skeletal system of living cells (Mahankali et al., 2015). AURKC and AURKA share
60% homology (Quintas-Cardama et al., 2007) and have been shown to have other
overlapping functions in meiotic cells. For example, AURKC can localize to spindle
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poles in meiotic cells to aid in centrosome clustering (Balboula et al., 2016). AURKC
may also share non-mitotic functions with AURKA.
Another potential mechanism by which AURKC expression is increasing cell
migration is through the Focal adhesion kinase (FAK) signaling pathway. A prior study
reported that AURKA promoted cell migration in head and neck squamous cell
carcinoma cells through its involvement with the AURKA/FAK signaling pathway (Wu
et al., 2016). In addition, AURKB has been tied to the FAK signaling pathway, in that
dual inhibition of AURKB and FAK synergistically impaired sarcoma cell viability and
significantly inhibited tumor progression (Wang et al., 2019). Based on these previous
studies and the known sequence and functional homology shared between AURKC and
the other two Aurora kinases, it can be inferred that AURKC may play a role in cell
migration through an involvement with the FAK signaling pathway.
Overall, this study found a significant increase in the cell migration rate and
anchorage independent growth in normal human cells when AURKC was expressed, both
key characteristics of transformation. Cell proliferation was not altered by AURKC
expression, but previous studies on level of kinase expression and untested cell growth
periods merit consideration for future studies. The results observed in this study suggest
that AURKC could serve as a potential target for therapeutic purposes in the future. In
fact, the Gantar lab is currently investigating how the deletion of AURKC via CRISPRCas9 system in cancer cells alters cell behavior. The use of meiosis-specific genes, such
as AURKC, as therapeutic targets represents an exciting field for developing novel cancer
therapeutics in the future.
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Appendix
Homo sapiens aurora kinase C (AURKC), transcript variant 1, mRNA, CDS
ATGGCTACAGCAAACCAAACAGCCCAGCAGCCCAGCAGCCCAGCCATGCGG
CGCCTCACAGTCGATGACTTTGAAATCGGGCGTCCCCTGGGCAAGGGGAAAT
TTGGGAATGTGTACCTGGCTCGGCTCAAGGAAAGCCATTTCATTGTGGCCCTG
AAGGTTCTCTTCAAGTCGCAGATAGAGAAGGAAGGACTGGAGCACCAGCTGC
GCCGGGAAATTGAGATCCAGGCTCATCTACAACACCCCAATATCCTGCGCCT
GTATAACTATTTCCATGATGCACGCCGGGTGTACCTGATTCTGGAATATGCTC
CAAGGGGTGAGCTCTACAAGGAGCTGCAGAAAAGCGAGAAATTAGATGAAC
AGCGCACAGCCACGATAATAGAGGAGTTGGCAGATGCCCTGACCTACTGCCA
TGACAAGAAAGTGATTCACAGAGATATTAAGCCAGAGAACCTGCTGCTGGGG
TTCAGGGGTGAGGTGAAGATTGCAGATTTTGGCTGGTCTGTGCACACCCCCTC
CCTGAGGAGGAAGACAATGTGTGGGACACTGGACTACTTGCCGCCAGAAATG
ATTGAGGGGAGAACATATGATGAAAAGGTGGATTTGTGGTGCATTGGAGTGC
TCTGCTATGAGCTGCTGGTGGGATATCCACCCTTTGAGAGCGCCTCCCACAGT
GAGACTTACAGACGCATCCTCAAGGTAGATGTGAGGTTTCCACTATCAATGC
CTCTGGGGGCCCGGGACTTGATTTCCAGGCTTCTCAGATACCAGCCCTTGGAG
AGACTGCCCCTGGCCCAGATCCTGAAGCACCCCTGGGTTCAGGCCCACTCCC
GAAGGGTGCTGCCTCCCTGTGCTCAGATGGCTTCCTGA

Infusion Cloning Primer Sequences
Forward:
GGTAGATGTGAGGTTTCCACTATC
Reverse:
GAACGTATCTACAGTTTACTCCCTATC
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pTetOne Sequence
TTTACGAGGGTAGGAAGTGGTACGGAAAGTTGGTATAAGACAAAAGTGTTGT
GGAATTGAAGTTTACTCAAAAAATCAGCACTCTTTTATAGGCGCCCTGGTTTA
CATAAGCAAAGCTTATACGTTCTCTATCACTGATAGGGAGTAAACTGGATAT
ACGTTCTCTATCACTGATAGGGAGTAAACTGTAGATACGTTCTCTATCACTGA
TAGGGAGTAAACTGGTCATACGTTCTCTATCACTGATAGGGAGTAAACTCCTT
ATACGTTCTCTATCACTGATAGGGAGTAAAGTCTGCATACGTTCTCTATCACT
GATAGGGAGTAAACTCTTCATACGTTCTCTATCACTGATAGGGAGTAAACTC
GAGAGAGAAATGTTCTGGCACCTGCACTTGCACTGGGGACAGCCTATTTTGC
TAGTTTGTTTTGTTTCGTTTTGTTTTGATGGAGAGCGTATGTTAGTACTATCGA
TTCACACAAAAAACCAACACACAGATGTAATGAAAATAAAGATATTTTATTC
TCGAGGTGATAATTCCACGGGGTTGGGGTTGCGCCTTTTCCAAGGCAGCCCTG
GGTTTGCGCAGGGACGCGGCTGCTCTGGGCGTGGTTCCGGGAAACGCAGCGG
CGCCGACCCTGGGTCTCGCACATTCTTCACGTCCGTTCGCAGCGTCACCCGGA
TCTTCGCCGCTACCCTTGTGGGCCCCCCGGCGACGCTTCCTGCTCCGCCCCTA
AGTCGGGAAGGTTCCTTGCGGTTCGCGGCGTGCCGGACGTGACAAACGGAAG
CCGCACGTCTCACTAGTACCCTCGCAGACGGACAGCGCCAGGGAGCAATGGC
AGCGCGCCGACCGCGATGGGCTGTGGCCAATAGCGGCTGCTCAGCAGGGCGC
GCCGAGAGCAGCGGCCGGGAAGGGGCGGTGCGGGAGGCGGGGTGTGGGGCG
GTAGTGTGGGCCCTGTTCCTGCCCGCGCGGTGTTCCGCATTCTGCAAGCCTCC
GGAGCGCACGTCGGCAGTCGGCTCCCTCGTTGACCGAATCACCGACCTCTCT
CCCCAGGGGGATCATCGAATTACCATGTCTAGACTGGACAAGAGCAAAGTCA
TAAACTCTGCTCTGGAATTACTCAATGGAGTCGGTATCGAAGGCCTGACGAC
AAGGAAACTCGCTCAAAAGCTGGGAGTTGAGCAGCCTACCCTGTACTGGCAC
GTGAAGAACAAGCGGGCCCTGCTCGATGCCCTGCCAATCGAGATGCTGGACA
GGCATCATACCCACTCCTGCCCCCTGGAAGGCGAGTCATGGCAAGACTTTCT
GCGGAACAACGCCAAGTCATACCGCTGTGCTCTCCTCTCACATCGCGACGGG
GCTAAAGTGCATCTCGGCACCCGCCCAACAGAGAAACAGTACGAAACCCTGG
AAAATCAGCTCGCGTTCCTGTGTCAGCAAGGCTTCTCCCTGGAGAACGCACT
GTACGCTCTGTCCGCCGTGGGCCACTTTACACTGGGCTGCGTATTGGAGGAAC
AGGAGCATCAAGTAGCAAAAGAGGAAAGAGAGACACCTACCACCGATTCTA
TGCCCCCACTTCTGAAACAAGCAATTGAGCTGTTCGACCGGCAGGGAGCCGA
ACCTGCCTTCCTTTTCGGCCTGGAACTAATCATATGTGGCCTGGAGAAACAGC
TAAAGTGCGAAAGCGGCGGGCCGACCGACGCCCTTGACGATTTTGACTTAGA
CATGCTCCCAGCCGATGCCCTTGACGACTTTGACCTTGATATGCTGCCTGCTG
ACGCTCTTGACGATTTTGACCTTGACATGCTCCCCGGGTAAATCTCCAGAGGA
TCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTC
CCACACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAA
CTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATT
TCACAAATAAAGCATTTTTTTCACTGCCCCGAGCTTCCTCGCTCACTGACTCG
CTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGG
TAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAG
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CAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGT
TTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCT
GTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTA
GGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTC
CAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGG
ATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGC
CTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAA
GCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACC
ACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAA
AAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAG
TGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGA
TCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGT
ATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCAC
CTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCG
TGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAAT
GATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCA
TCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAAT
AGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTC
GTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACAT
GATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTT
GTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGC
ATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAG
TACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTG
CCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTG
CTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCT
GTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCAT
CTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGC
CGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTC
CTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATA
CATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTT
CCCCGAAAAGTGCCACCTGACGTCGGCAGTGAAAAAAATGCTTTATTTGTGA
AATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTGCAATAAACAAG
TTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGG
GAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATGTGGTATGGCTGATTATG
ATCCTCTAGACATATGCTGCAGAGATCTGGATCCACCGGTATCGATACGCGT
GCGGCCGCGAATTC
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